| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Dicerna Pharmaceuticals Inc (F: DPL)
DPL Technical Analysis
5
| As on 28th Dec 2021 DPL STOCK Price closed @ 33.51 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 22.45 & Strong Buy for SHORT-TERM with Stoploss of 18.47 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DPLSTOCK Price
| Open | 33.51 | Change | Price | % |
| High | 33.51 | 1 Day | 0.00 | 0.00 |
| Low | 33.51 | 1 Week | -0.25 | -0.74 |
| Close | 33.51 | 1 Month | 14.49 | 76.18 |
| Volume | N/A | 1 Year | 17.61 | 110.75 |
| 52 Week High 34.03 | 52 Week Low 15.40 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| DPL Daily Charts |
DPL Intraday Charts |
Whats New @ Bazaartrend |
DPL Free Analysis |
|
|
DPL Important Levels Intraday
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
| RESISTANCE | 33.51 |
DPL Forecast June 2025
| 4th UP Forecast | 38.52 |
| 3rd UP Forecast | 36.91 |
| 2nd UP Forecast | 35.92 |
| 1st UP Forecast | 34.93 |
| 1st DOWN Forecast | 32.09 |
| 2nd DOWN Forecast | 31.1 |
| 3rd DOWN Forecast | 30.11 |
| 4th DOWN Forecast | 28.5 |
DPL Weekly Forecast
| 4th UP Forecast | 35.63 |
| 3rd UP Forecast | 34.95 |
| 2nd UP Forecast | 34.53 |
| 1st UP Forecast | 34.11 |
| 1st DOWN Forecast | 32.91 |
| 2nd DOWN Forecast | 32.49 |
| 3rd DOWN Forecast | 32.07 |
| 4th DOWN Forecast | 31.39 |
DPL Forecast2025
| 4th UP Forecast | 69.41 |
| 3rd UP Forecast | 57.9 |
| 2nd UP Forecast | 50.78 |
| 1st UP Forecast | 43.66 |
| 1st DOWN Forecast | 23.36 |
| 2nd DOWN Forecast | 16.24 |
| 3rd DOWN Forecast | 9.12 |
| 4th DOWN Forecast | -2.39 |
Dicerna Pharmaceuticals Inc ( F Germany Symbol : DPL )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DPL Business Profile
Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. Address: 75 Hayden Avenue, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service